Quick Takeaways
- PPBT - PURPLE BIOTECH LTD. has 7 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 7 Insiders of PURPLE BIOTECH LTD.
- Symbol
- PPBT on Nasdaq
- Location
- Rehovot, Israel
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 08 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
PURPLE BIOTECH LTD. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Gil Efron | Chief Executive Officer | $10,355,625 | Mixed | 18 Mar 2026 | ||
| Michael Schickler | Head of Clinical & Reg Affairs | $6,084,815 | Mixed | 18 Mar 2026 | ||
| Shai S. Lankry | Chief Financial Officer | $2,334,125 | Mixed | 18 Mar 2026 | ||
| Ido Agmon | Director | $2,034,212 | Mixed | 18 Mar 2026 | ||
| Robert E. Gagnon | Director | $1,531,250 | Mixed | 18 Mar 2026 | ||
| Simcha Rock | Director | $1,411,384 | Market | 18 Mar 2026 | ||
| Suzana Zilberberg | Director | $1,347,500 | Market | 18 Mar 2026 |
Top shareholders of PURPLE BIOTECH LTD. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC |
13D/G
|
Mitchell P. Kopin |
10%
|
200,453,695
|
$113,957,926 | +$34,576,864 | 30 Sep 2025 | |
| SUSQUEHANNA SECURITIES, LLC |
13D/G
|
— |
5.2%
|
93,953,400
|
$63,888,312 | $0 | 31 Dec 2025 | |
| Gil Efron |
3/4/5
|
Chief Executive Officer |
0.87%
|
15,750,000
|
$10,355,625 | — | 18 Mar 2026 | |
| Michael Schickler |
3/4/5
|
Head of Clinical & Reg Affairs |
0.51%
|
9,254,472
|
$6,084,815 | — | 18 Mar 2026 | |
| Shai S. Lankry |
3/4/5
|
Chief Financial Officer |
0.2%
|
3,550,000
|
$2,334,125 | — | 18 Mar 2026 | |
| Ido Agmon |
3/4/5
|
Director |
0.17%
|
3,093,860
|
$2,034,212 | — | 18 Mar 2026 | |
| Robert E. Gagnon |
3/4/5
|
Director |
0.17%
|
3,062,500
|
$1,531,250 | — | 18 Mar 2026 | |
| Simcha Rock |
3/4/5
|
Director |
0.18%
|
3,207,690
|
$1,411,384 | — | 18 Mar 2026 | |
| Suzana Zilberberg |
3/4/5
|
Director |
0.17%
|
3,062,500
|
$1,347,500 | — | 18 Mar 2026 | |
| Lincoln Alternative Strategies LLC |
13D/G
|
— |
9.9%
|
605,000
|
$1,288,650 | $0 | 04 Sep 2025 | |
| Orca Capital AG |
13D/G
|
— |
4.9%
|
306,394
|
$652,619 | $0 | 04 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
469,767
|
$308,872 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.01%
|
155,353
|
$102,145 | — | 31 Dec 2025 | |
| SmartHarvest Portfolios, LLC |
13F
|
Company |
0%
|
47,454
|
$31,201 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0%
|
42,737
|
$28,100 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
21,075
|
$13,857 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0%
|
14,700
|
$9,665 | — | 31 Dec 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
9,231
|
$6,069 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
7,392
|
$4,860 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
6,091
|
$4,005 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,098
|
$2,035 | — | 31 Dec 2025 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
2,836
|
$1,865 | — | 31 Dec 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
320
|
$210 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
294
|
$193 | — | 31 Dec 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
85
|
$56 | — | 31 Dec 2025 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
56
|
$37 | — | 31 Dec 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
50
|
$33 | — | 31 Dec 2025 | |
| Global Retirement Partners, LLC |
13F
|
Company |
0%
|
16
|
$11 | — | 31 Dec 2025 | |
| Tradewinds Capital Management, LLC |
13F
|
Company |
0%
|
10
|
$7 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for PURPLE BIOTECH LTD.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Simcha Rock | PPBT | Ordinary Shares | 0 | 3,207,690 | 18 Mar 2026 | Direct | ||||
| Suzana Zilberberg | PPBT | Ordinary Shares | 0 | 3,062,500 | 18 Mar 2026 | Direct | ||||
| Ido Agmon | PPBT | Ordinary Shares | 0 | 3,093,860 | 18 Mar 2026 | Direct | ||||
| Gil Efron | PPBT | Ordinary Shares | 0 | 15,750,000 | 18 Mar 2026 | Direct | ||||
| Shai S. Lankry | PPBT | Ordinary Shares | 0 | 3,550,000 | 18 Mar 2026 | Direct | ||||
| Michael Schickler | PPBT | Ordinary Shares | 0 | 9,254,472 | 18 Mar 2026 | Direct | ||||
| Robert E. Gagnon | PPBT | Ordinary Shares | 0 | 3,062,500 | 18 Mar 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.